Marco Valgimigli

Professor of Medicine

Università della Svizzera italiana Facoltà di scienze biomediche

Switzerland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

100%

Internal Medicine

30%

Coronary Artery Disease

100%

Thrombosis

90%

Transcatheter Interventions

70%

Coronary Intervention

40%

Ischemic Medicine

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution

Article Link

Year:

2024

Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome

Article Link

Year:

2024

Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial

Article Link

Year:

2024

Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial

Article Link

Year:

2024

Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials

Article Link

Year:

2024

Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial

Article Link

Year:

2023

Vascular Access in Percutaneous Coronary Intervention of Chronic Total Occlusions: A State-of-the-Art Review

Article Link

Year:

2023

Antithrombotic therapy in patients with established atherosclerotic coronary disease

Article Link

Year:

2023

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC)

Article Link

Year:

2023

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials

Article Link

Year:

2023

Sailing in the complexity of the ‘shark-fin’ sign

Article Link

Year:

2023

Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials

Article Link

Year:

2023

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis

Article Link

Year:

2022

Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge

Article Link

Year:

2022

Not only lungs: COVID-19 hits platelets as well

Article Link

Year:

2022

Management of acute coronary syndromes in older adults

Article Link

Year:

2022

Collaborators10

Sunil V. Rao

UNITED STATES

Dan Atar

Professor of Cardiology and Head of Research

Oslo University Hospital

NORWAY

Francesco Costa

University of Messina

ITALY

Victor Aboyans

FRANCE

henning kelbæk

Chief physician

Zealand University Hospital

DENMARK

Robert Storey

University of Sheffield

UNITED KINGDOM

Sergio Leonardi

Università degli Studi di Pavia

ITALY

David Erlinge

Lund University

SWEDEN

Vijay Kunadian

Newcastle University

UNITED KINGDOM

Gabor Toth G

Medical University of Graz

AUSTRIA

How do I reach out?

Meet Kite AI